Ying Liu

31PUBLICATIONS
231CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersForensic epidemiologyNeurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 27, 2026
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0.

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Jan 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.

Judy J Wang, Juliet Milani, Sarah Kane

Pageof 6